or Try an Advanced Search...

    Technical Analysis for EPIX - ESSA Pharma Inc.

    Grade Last Price % Change Price Change
    D 6.08 -0.65% -0.04
    EPIX closed down 0.65 percent on Friday, April 26, 2024, on 2.25 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 7
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical EPIX trend table...
    Date Alert Name Type % Chg
    200 DMA Support Bullish 0.00%
    Doji - Bullish? Reversal 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New Downtrend Bearish -0.65%
    Wide Bands Range Expansion -0.65%
    Oversold Stochastic Weakness -0.65%
    NR7 Range Contraction -2.72%
    Narrow Range Bar Range Contraction -2.72%
    Older End-of-Day Signals for EPIX ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Support about 18 hours ago
    2x Volume Pace about 18 hours ago
    1.5x Volume Pace about 18 hours ago
    Down 5% about 18 hours ago
    Down 3% about 18 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    EPIX Chart by TradingView
    Basic chart:

    Profile

    ESSA Pharma Inc. is a pharmaceutical company. The company focused on the development of small molecule drugs for the treatment of cancer, with focus on advanced prostate cancer. ESSA Pharma Inc. is based in Vancouver, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Cancer Pharmaceutical Treatment Of Cancer Prostate Cancer Histopathology Advanced Prostate Cancer Pharma

    Is EPIX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 9 ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
    Apr 8 ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
    Mar 8 ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
    Feb 26 12 $10 Stocks That Will Triple
    Feb 16 EPIX: Risk Profile of Patients in Phase 1/2 Trial of Masofaniten Reveals Majority at High Risk for Early Enzalutamide Failure…
    Feb 14 ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results
    Feb 13 ESSA Pharma GAAP EPS of -$0.14
    Feb 13 ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023
    Feb 8 ESSA Pharma Inc Executive Peter Virsik Sells 72,782 Shares
    Feb 6 ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    See more EPIX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.67
    52 Week Low 2.56
    Average Volume 79,342
    200-Day Moving Average 5.76
    50-Day Moving Average 8.28
    20-Day Moving Average 7.36
    10-Day Moving Average 6.61
    Average True Range 0.63
    RSI (14) 25.37
    ADX 27.0
    +DI 9.10
    -DI 26.39
    Chandelier Exit (Long, 3 ATRs) 7.30
    Chandelier Exit (Short, 3 ATRs) 7.60
    Upper Bollinger Bands 9.03
    Lower Bollinger Band 5.68
    Percent B (%b) 0.12
    BandWidth 45.51
    MACD Line -0.67
    MACD Signal Line -0.54
    MACD Histogram -0.1257
    Fundamentals Value
    Market Cap 268.51 Million
    Num Shares 44.2 Million
    EPS -0.60
    Price-to-Earnings (P/E) Ratio -10.13
    Price-to-Sales 0.00
    Price-to-Book 3.09
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.85
    Resistance 3 (R3) 6.81 6.51 6.72
    Resistance 2 (R2) 6.51 6.32 6.53 6.67
    Resistance 1 (R1) 6.30 6.20 6.15 6.34 6.63
    Pivot Point 6.00 6.00 5.93 6.02 6.00
    Support 1 (S1) 5.79 5.81 5.64 5.83 5.53
    Support 2 (S2) 5.49 5.69 5.51 5.49
    Support 3 (S3) 5.28 5.49 5.44
    Support 4 (S4) 5.32